3 years ago was a proposed EAP on Multiple Sclerosis and 1102 that I questioned at the time as unlikely Acromegaly agreement 1103 was only implemented in December last year and completely different ball game.
It's all about DMD but just highlighting your confusion with 2 different EAP's with 2 different targets and 2 different compounds.
- Forums
- ASX - By Stock
- PER
- Biomarker
Biomarker, page-15
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
7.9¢ |
Change
-0.002(1.88%) |
Mkt cap ! $70.77M |
Open | High | Low | Value | Volume |
8.0¢ | 8.2¢ | 7.8¢ | $66.20K | 831.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 216590 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 24573 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 216590 | 0.077 |
2 | 66500 | 0.076 |
4 | 206988 | 0.075 |
2 | 353708 | 0.074 |
2 | 87000 | 0.072 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 24573 | 1 |
0.080 | 299770 | 2 |
0.082 | 255785 | 2 |
0.083 | 134797 | 3 |
0.084 | 157142 | 2 |
Last trade - 15.45pm 17/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |